LivaNova PLC (LIVN) Sees Large Volume Increase
LivaNova PLC (NASDAQ:LIVN) shares saw strong trading volume on Monday . 273,918 shares traded hands during mid-day trading, an increase of 8% from the previous session’s volume of 252,971 shares.The stock last traded at $60.60 and had previously closed at $59.79.
A number of analysts have issued reports on the stock. WBB Securities reiterated a “hold” rating and issued a $60.00 target price on shares of LivaNova PLC in a research note on Wednesday, August 31st. Piper Jaffray Cos. reiterated an “overweight” rating and issued a $70.00 target price (up from $59.00) on shares of LivaNova PLC in a research note on Friday, August 5th. Six research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $67.20.
The stock’s market capitalization is $2.95 billion. The firm has a 50 day moving average price of $60.48 and a 200 day moving average price of $53.78.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/19/livanova-plc-livn-sees-large-volume-increase.html
In related news, insider Jacques Gutedel sold 4,000 shares of the stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $60.52, for a total transaction of $242,080.00. Following the completion of the sale, the insider now directly owns 10,948 shares of the company’s stock, valued at approximately $662,572.96. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder Two S.C.A. Equinox sold 75,213 shares of the stock in a transaction that occurred on Friday, September 16th. The stock was sold at an average price of $59.86, for a total value of $4,502,250.18. The disclosure for this sale can be found here. 0.70% of the stock is owned by insiders.
A number of hedge funds have recently bought and sold shares of the company. JPMorgan Chase & Co. boosted its stake in LivaNova PLC by 7.6% in the first quarter. JPMorgan Chase & Co. now owns 108,324 shares of the company’s stock worth $5,847,000 after buying an additional 7,607 shares during the last quarter. A.R.T. Advisors LLC boosted its stake in LivaNova PLC by 3.4% in the first quarter. A.R.T. Advisors LLC now owns 54,115 shares of the company’s stock worth $2,921,000 after buying an additional 1,800 shares during the last quarter. BlueMountain Capital Management LLC acquired a new stake in LivaNova PLC during the first quarter worth about $973,000. BNP Paribas Arbitrage SA boosted its stake in LivaNova PLC by 2,043.9% in the second quarter. BNP Paribas Arbitrage SA now owns 18,845 shares of the company’s stock worth $947,000 after buying an additional 17,966 shares during the last quarter. Finally, 1832 Asset Management L.P. boosted its stake in LivaNova PLC by 3.4% in the first quarter. 1832 Asset Management L.P. now owns 54,600 shares of the company’s stock worth $4,922,000 after buying an additional 1,800 shares during the last quarter. 63.67% of the stock is owned by institutional investors and hedge funds.
About LivaNova PLC
LivaNova PLC is a medical technology company. The Company operates through three segments: Cardiac Surgery, Cardiac Rhythm Management (CRM) and Neuromodulation. The Cardiac Surgery business unit is engaged in the development, production and sale of cardiovascular surgery products, including oxygenators, heart-lung machines, perfusion tubing systems and systems for autotransfusion and autologous blood washing.
Receive News & Ratings for LivaNova PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for LivaNova PLC and related companies with MarketBeat.com’s FREE daily email newsletter.